compounding pharmacy glp 1 glp-1 GLP-1 Compound versions of GLP-1 drugs
Description
Sarah Mess.
Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.
Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive
Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors
